InsidersTradesSigma
Track the Alphamab Oncology - B stock price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Market capitalisation: €7.9bn. The latest transaction was filed on 23 June 2026 (Purchase). Among the most active insiders: LIU Yang. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Alphamab Oncology - B 是一家专注于开发创新癌症治疗方法的公司。它专门从事基于单克隆抗体的疗法的研究和商业化。